U.S. Personalized Medicine Market 2018 |New Business Opportunities and Investment | Most Eminent Players- Laboratory Corporation of America, Quest Diagnostics, Abbott, Becton Dickinson & Co., Siemens Healthcare Diagnostics Inc. and More

An expert on premium research reports, Market Research Future has added a report titled " U.S. Personalized Medicine Market Research Report - Forecast To 2023" to its offering. The report provides an in-depth analysis of regional data and an accurate projection of the market size and share of the Top 10 market players across the globe.

The Report analyzes individual submarkets for personalized medicine in the United States in terms of technology, products, services, application areas and geography.

Personalized medicine has cropped up as a new treatment paradigm to treatment and patient care. Personalized medicine promises to get the right treatment to the right patient at the right time through the use of targeted therapies. It is an emerging field of medicine that enables early detection of diseases at the molecular level. The US personalized medicine market is perceived to be a steadily growing market at a CAGR of 7.5% over the forecast period of 2017-2023, asserts Market Research Future (MRFR) in a detailed research report.

Get Sample Copy @

https://www.marketresearchfuture.com/reports/personalized-medicine-market-2937

Various trends are responsible for influencing the growth trajectory of the US personalized medicine market. Personalized medicine promises enormous potential in the treatment of cancer. Personalized medicine has entered the mainstream in the treatment of oncology diseases and is changing the way such diseases are identified, treated and classified. According to the World Health Organization (WHO), cancer is one of the prime reasons for 31% of the deaths globally and each year about 17.5 Mn people die due to cancer. Surging prevalence of cancer across the US is a prime reason for the growth of the US personalized medicine market.

Strong research & development activities in the field of personalized medicine by industrial, academic, and government agencies continue to remain strong in the region which also supports the growth of the US personalized medicine market.

Increasing incidences of autoimmune diseases stimulate the growth of the US personalized medicine market. Also, the government in the US is extending its support in the form of funding for R&D activities; favorable NIH policies create a conducive environment for the growth of the US personalized medicine market.

Furthermore, a growing number of companies from outside the health industry are entering the personalized medicine space which is likely to provide an impetus to the growth of the US personalized medicine market.

Competitive Landscape

Personalized medicine is presenting new challenges as well as opportunities to the market players who are continually endeavoring make their mark in the market. Collaborations through mergers, acquisitions, partnerships, and others are key strategies utilized by the market participants to stay competitive and improve their product offerings. Sanofi, Pfizer Inc., Laboratory Corporation of America, Abbott, Becton Dickinson & Co., Quest Diagnostics, GE Healthcare,

CardioDx Inc., Asuragen Inc., Bristol-Myers Squibb, Siemens Healthcare Diagnostics Inc., are the notable players in the US personalized medicine market.

Segmentation

The US personalized medicine market has been segmented based on product, application, and end user. By product, the US personalized medicine market has been segmented into diagnostic, therapeutics, medical care and nutrition, and wellness and others. The diagnostic and therapeutic segment accounts for the largest share of the market.

By application, the US personalized medicine market has been segmented into diagnosis and intervention, drug development and usage, cancer genomics and others.

By end user, the US personalized medicine market has been segmented into hospitals, molecular diagnostic laboratories and testing centers, academic institutes, bio & health informatics companies, and others. End user-wise, the hospitals segment commands the largest share of the market owing to growing usage in hospitals. The molecular diagnostic laboratories and testing centers segment is the second largest segment.

Industry Updates

In December 2018, researchers at the University of Utah developed a novel personalized medicine tool for inherited colorectal cancer syndrome. The results for the same was published in the journal Genetics in Medicine.
In December 2018, researchers at the Columbia University have made advancements in personalized medicine that can be helpful in the treatment of kidney diseases.
Browse Complete 110 Pages Premium Research Report Enabled with 77 Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/personalized-medicine-market-2937

Detailed Table of Contents:

Table Of Contents

1 Introduction

1.1 Definition

1.2 Scope Of Study

1.2.1 Research Objective

1.2.2 Assumptions & Limitations

1.2.2.1 Assumptions

1.2.2.2 Limitations

1.3 Market Structure:

2 Research Methodology

2.1 Research Process:

2.2 Primary Research

2.3 Secondary Research:

3 Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Macroeconomic Indicators

List Of Tables and Figures

List Of Tables

Table 1 U.S. Personalised Medicine Market, By Product, 2017-2023 (Usd Million)

Table 2 U.S. Personalised Medicine Market, By Application, 2017-2023 (Usd Million)

Table 3 U.S. Personalised Medicine Marketby End Users 2017-2023 (Usd Million)

Table 4 U.S. Personalised Medicine Market, By Region 2017-2023 (Usd Million)

List Of Figures

Figure 1 Research Process

Figure 2 Porters Five Forces Model

Figure 3 U.S. Personalised Medicine Market, By Product

Figure 4 U.S. Personalised Medicine Market, By Application

Figure 5 U.S. Personalised Medicine Market, By End Users

Figure 6 U.S. Personalised Medicine Market, By Region

Figure 7 U.S. Personalised Medicine Market: Company Share Analysis, 2016 (%)

...Continued!

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.